Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Inhibiteur de la phosphodiestérase 5")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 560

  • Page / 23
Export

Selection :

  • and

Role of Growth Factors in Improved Skin Flap Viability Caused by Phosphodiesterase-5 InhibitorBANDERA, Bradley C; PHAM, Thach; HILL-PRYOR, Crystal et al.The American surgeon. 2010, Vol 76, Num 6, pp 614-617, issn 0003-1348, 4 p.Article

Is phosphodiesterase type 5 inhibitor use associated with condom breakage? CommentaryCROSBY, R; YARBER, W. L; SANDERS, S. A et al.Sexually transmitted infections. 2009, Vol 85, Num 5, pp 404-406, issn 1368-4973, 3 p.Article

Isolation and structure elucidation of an interaction product of aminotadalafil found in an illegal health food productHÄBERLI, Adrian; GIRARD, Philippe; LOW, Min-Yong et al.Journal of pharmaceutical and biomedical analysis. 2010, Vol 53, Num 1, pp 24-28, issn 0731-7085, 5 p.Article

Lifestyle and metabolic approaches to maximizing erectile and vascular healthMELDRUM, D. R; GAMBONE, J. C; MORRIS, M. A et al.International journal of impotence research. 2012, Vol 24, Num 2, pp 61-68, issn 0955-9930, 8 p.Article

Effects of phosphodiesterase type 5 inhibitors on endothelial function and cardiovascular autonomic nerve function in menSTIRBAN, Alin; TAMLER, Ronald; ANDREI VERESIU, Loan et al.Journal of men's health (Print). 2011, Vol 8, Num 2, pp 109-118, issn 1875-6867, 10 p.Article

Phosphodiesterase-5 inhibitors and rosacea : report of 10 casesIOANNIDES, D; LAZARIDOU, E; APALLA, Z et al.British journal of dermatology (1951). 2009, Vol 160, Num 3, pp 719-720, issn 0007-0963, 2 p.Article

How to optimise treatment of erectile dysfunction above and beyond the beneficial effects of a phosphodiesterase type 5 inhibitorGOOREN, Louis.Journal of men's health. 2008, Vol 5, Num 2, pp 163-170, 8 p.Article

Structural elucidation of a PDE-5 inhibitor detected as an adulterant in a health supplementXIAOWEI GE; LOW, Min-Yong; PENG ZOU et al.Journal of pharmaceutical and biomedical analysis. 2008, Vol 48, Num 4, pp 1070-1075, issn 0731-7085, 6 p.Article

Erectile Dysfunction and Cardiovascular Disease : Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors in Men With Both ConditionsNEHRA, Ajay.Mayo Clinic proceedings. 2009, Vol 84, Num 2, pp 139-148, issn 0025-6196, 10 p.Article

Alprostadil for the treatment of impotenceHANCHANALE, Vishwanath; EARDLEY, Ian.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 3, pp 421-428, issn 1465-6566, 8 p.Article

Is there a role for phosphodiesterase type-5 inhibitors in the treatment of premature ejaculation?AVERSA, A; FRANCOMANO, D; BRUZZICHES, R et al.International journal of impotence research. 2011, Vol 23, Num 1, pp 17-23, issn 0955-9930, 7 p.Article

Erectile dysfunction and heart failure : the role of phosphodiesterase type 5 inhibitorsAL-AMERI, H; KLONER, R. A.International journal of impotence research. 2009, Vol 21, Num 3, pp 149-157, issn 0955-9930, 9 p.Article

Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction : results from the Erectile Dysfunction Observational StudyHATZICHRISTOU, D; HARE, J. M; MARTIN-MORALES, A et al.International journal of clinical practice (Esher). 2007, Vol 61, Num 11, pp 1850-1862, issn 1368-5031, 13 p.Article

Management of Benign Prostatic Hyperplasia: Role of Phosphodiesterase-5 InhibitorsGACCI, M; CARINI, M; SERNI, S et al.Drugs & aging. 2014, Vol 31, Num 6, pp 425-439, issn 1170-229X, 15 p.Article

Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database studyKIRBY, M. G; SCHNETZLER, G; ZOU, K. H et al.International journal of clinical practice (Esher). 2011, Vol 65, Num 7, pp 797-806, issn 1368-5031, 10 p.Article

The Contributions of Cytochromes P450 3A4 and 3A5 to the Metabolism of the Phosphodiesterase Type 5 Inhibitors Sildenafil, Udenafil, and VardenafilKU, Hei-Young; AHN, Hee-Jeong; SEO, Kyung-Ah et al.Drug metabolism and disposition. 2008, Vol 36, Num 6, pp 986-990, issn 0090-9556, 5 p.Article

Long-term Inhaled Nitric Oxide Plus Phosphodiesterase 5 Inhibitors for Severe Pulmonary HypertensionPEREZ-PENATE, Gregorio Miguel; JULIA-SERDA, Gabriel; OJEDA-BETANCORT, Nazario et al.The Journal of heart and lung transplantation. 2008, Vol 27, Num 12, pp 1326-1332, issn 1053-2498, 7 p.Article

Sildenafil citrate improves sperm motility but causes a premature acrosome reaction in vitroGLENN, David R. J; MCVICAR, Carmel M; MCCLURE, Neil et al.Fertility and sterility. 2007, Vol 87, Num 5, pp 1064-1070, issn 0015-0282, 7 p.Article

Sildenafil citrate in the treatment of sexual dysfunction and its effect on quality of life in alcohol dependent men : Preliminary findingsGRINSHPOON, Alexander; MARGOLIS, Anatoly; WEIZMAN, Abraham et al.Alcohol and alcoholism (Oxford). 2007, Vol 42, Num 4, pp 340-346, issn 0735-0414, 7 p.Article

Expression, distribution and regulation of phosphodiesterase 5 : Phosphodiesterase 5 inhibitors : pharmacology and therapeutic perspectivesLIN, Ching-Shwun; GUITING LIN; XIN, Zhong-Cheng et al.Current pharmaceutical design. 2006, Vol 12, Num 27, pp 3439-3457, issn 1381-6128, 19 p.Article

Modeling and simulation of sexual activity daily diary data of patients with female sexual arousal disorder treated with sildenafil citrate (Viagra®)CLARET, Laurent; COX, Eugene H; MCFADYEN, Lynn et al.Pharmaceutical research. 2006, Vol 23, Num 8, pp 1756-1764, issn 0724-8741, 9 p.Article

The effects of pummelo juice on pharmacokinetics of sildenafil in healthy adult male Jordanian volunteersAL-GHAZAWI, Mutasim A; TUTUNJI, Maha S; ABURUZ, Salah M et al.European journal of clinical pharmacology. 2010, Vol 66, Num 2, pp 159-163, issn 0031-6970, 5 p.Article

Combined use of phosphodiesterase-5 inhibitors and selective serotonin reuptake inhibitors for temporary ejaculation failure in couple undergoing assisted reproductive technologiesSHAOMING LU; YUERAN ZHAO; JINGMEI HU et al.Fertility and sterility. 2009, Vol 91, Num 5, pp 1806-1808, issn 0015-0282, 3 p.Article

Relaxant Effects of Sildenafil on the Human Isolated Bladder NeckBITTENCOURT, José Augusto F; TANO, Tania; GAJAR, Sessin A et al.Urology (Ridgewood, NJ). 2009, Vol 73, Num 2, pp 427-430, issn 0090-4295, 4 p.Article

Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunctionTHURTELL, M. J; TOMSAK, R. L.International journal of impotence research. 2008, Vol 20, Num 6, pp 537-543, issn 0955-9930, 7 p.Article

  • Page / 23